Rheuminations Inc entered the industry of Medical Research in 2000 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 7139401, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Stephen A Paget by calling (212) 593-5180 during business hours. You can also write to the business’ Single Location at 142 West 57th St Floor 15, New York City, New York NY 10019. You can also visit the company’s website at dxlupus.org. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Rheuminations Inc |
Representative: | Stephen A Paget |
Place of Business: | 142 West 57th St Floor 15, New York City, NY 10019 |
Contact Number: | (212) 593-5180 |
Website: | dxlupus.org |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 7139401 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2000 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Rheuminations Inc is a company operating from New York, New York providing professional Medical Research and relevant B2B variables. It was founded in 2000 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 7139401 as Medical Research.
With a current employee count of 1 to 4, Rheuminations Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Stephen A Paget at (212) 593-5180 for related queries, or to locate its Single Location using the coordinates 40.764976,-73.978884.
The Single Location can also be found at the street address 142 West 57th St Floor 15 in New York City, New York 10019 and can be engaged online through the company website at dxlupus.org, the company Twitter , and Facebook page .